Citadel Advisors - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$236,000
+62.8%
48,076
+74.7%
0.00%
Q2 2021$145,000
-74.2%
27,527
-76.5%
0.00%
Q1 2021$562,000
+360.7%
117,046
+315.1%
0.00%
Q4 2020$122,000
+27.1%
28,200
+21.3%
0.00%
Q3 2020$96,000
+242.9%
23,241
+115.2%
0.00%
Q2 2020$28,000
-49.1%
10,800
-43.8%
0.00%
Q1 2020$55,000
-79.2%
19,232
-72.6%
0.00%
Q4 2019$265,000
-9.2%
70,154
+22.9%
0.00%
Q3 2019$292,0000.0%57,101
+21.0%
0.00%
Q2 2019$292,000
+12.7%
47,192
+29.3%
0.00%
Q1 2019$259,000
-64.1%
36,507
-56.8%
0.00%
Q4 2018$721,000
-65.7%
84,523
-19.6%
0.00%
Q3 2018$2,104,000
+13.2%
105,066
+46.1%
0.00%
Q2 2018$1,858,000
+19.0%
71,904
+10.0%
0.00%
Q1 2018$1,562,000
-86.0%
65,380
-80.1%
0.00%
-100.0%
Q4 2017$11,154,000
-34.6%
329,133
-59.1%
0.01%
-53.8%
Q3 2017$17,047,000
+2713.0%
805,265
+2225.5%
0.01%
+1200.0%
Q2 2017$606,000
+176.7%
34,628
+159.9%
0.00%
Q3 2016$219,000
-86.1%
13,323
-87.7%
0.00%
-100.0%
Q1 2016$1,572,000
-75.8%
108,747
-52.6%
0.00%
-71.4%
Q4 2015$6,495,000
+1417.5%
229,348
+1303.5%
0.01%
Q2 2015$428,000
-37.2%
16,341
-58.0%
0.00%
-100.0%
Q1 2015$682,000
-9.2%
38,952
-9.8%
0.00%0.0%
Q4 2014$751,000
+77.5%
43,206
+90.1%
0.00%
Q3 2014$423,00022,7310.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders